JPM highlights | WuXi Biologics CEO Dr. Chris Chen: Scaled CRDMO platform delivering sustainable high growth Post author:admin Post published:January 27, 2026 Post category:uncategorized JPM Highlights | WuXi Biologics CEO Dr. Chris Chen: Scaled CRDMO Platform Delivering Sustainable High Growth You Might Also Like DNA damage in gray matter neurons linked to MS progression April 1, 2026 New device simulates human diseases in multiple organs October 4, 2023 Artificial empathy in healthcare platforms and future directions January 5, 2026